CanadaBis Capital Inc. 從事娛樂用大麻及大麻提取物的生產與銷售。公司總部位於艾伯塔省紅鹿縣。该公司於2017年3月8日首次公開發行股票上市。公司的主要業務為娛樂用大麻及大麻提取物的生產與銷售。公司透過三個部門運營:種植與批發、零售以及提取物。種植與批發部門負責種植大麻並向各省酒類與大麻管理局及其管道分銷大麻和大麻產品,再由其銷售給終端消費者。其零售部門負責在公司擁有並經營的實體場所內向終端消費者銷售大麻及相關產品。提取物部門則透過其生產設施將產品 wholesale 銷售給分銷商和持牌大麻生產商。公司的子公司包括 Stigma Pharmaceuticals Inc.、1998643 Alberta Ltd.、Full Spectrum Labs Ltd.、2103157 Alberta Ltd. 和 Goldstream Cannabis Inc.
CNADF stock price ended at $0.02 on 星期五, after rising 0.00%
On the latest trading day Dec 19, 2025, the stock price of CNADF rose by 0.00%, climbing from $0.02 to $0.02. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $0.02 and a high of $0.02. Alongside this price increase, trading volume also rose by 90.0K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 10.0K shares were traded, amounting to a market value of approximately $2.7M.